Subscribe

Factors Affecting Reduction in Sperm Count for Man Treated with Cyclophosphamide (Cytoxan)

Purpose:

To evaluate the sperm count in a man treated with cyclophosphamide (Cytoxan) based on the study of Meistrich et al.

Specialty:

Hematology Oncology
Nephrology, Urology, Obstetrics & Gynecology, Pedatrics, Genetics

Objective:

risk factors, adverse effects

ICD-10:

T45.1

Description:

A man treated with cyclophosphamide (Cytoxan) may develop oligo or azoospermia afterwards. Meistich et al evaluated the impact of cyclophosphamide on the sperm count over time. The authors are from the University of Texas M.D. Anderson Cancer Center and Baylor College of Medicine in Houston.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone